11 results
Proton Pump Inhibitor (PPI) - Adverse Effects and Prescribing Tips

#Management #Pharmacology #PPI #Adverse #SideEffects #Prescribing #ProtonPumpInhibitor
Pump Inhibitor (PPI ... Adverse Effects and Prescribing ... Tips #Management ... #Pharmacology # ... PPI #Adverse #SideEffects
2021 ACR/VF Guidelines for Management of Granulomatosis with Polyangiitis (GPA) and Microscopic Polyangiitis (MPA)

#Granulomatosis #Polyangiitis #GPA
2021 ACR/VF Guidelines ... for Management ... and Microscopic Polyangiitis ... #MPA #ACR2021 #Management ... #rheumatology #
2021 ACR/VF Guidelines for Management of Eosinophilic Granulomatosis with Polyangiitis (EGPA)

#EGPA #Eosinophilic #Granulomatosis #Polyangiitis #ACR2021 #Management
2021 ACR/VF Guidelines ... for Management ... Granulomatosis #Polyangiitis ... #ACR2021 #Management ... #rheumatology #
Vasculitis Management - ACR/VF 2021 Guidelines for Treatment & Management
 • Giant Cell Arteritis (GCA)
 •
Vasculitis Management ... - ACR/VF 2021 Guidelines ... for Treatment & Management ... Treatment #ACR2021 #Guidelines ... #algorithm #rheumatology
Guidelines on De-Prescribing of Proton Pump Inhibitors

Best Practice Advice Statements
Long-term Indications for PPI use
Short-term Indications for
Guidelines on De-Prescribing ... Indications for PPI ... Indications for PPI ... EmoryGastroHep #DePrescribing ... #Guidelines #management
Granulomatosis with Polyangiitis (GPA) and Microscopic Polyangiitis (MPA) - ANCA Vasculitis Management Algorithm - ACR/VF 2021
ANCA Vasculitis Management ... - ACR/VF 2021 Guidelines ... ANCA #Vasculitis #Management ... Treatment #ACR2021 #Guidelines ... #algorithm #rheumatology
Deprescribing algorithm for proton pump inhibitors

To support clinicians in employing the recommendations outlined in the guideline,
Deprescribing algorithm ... outlined in the guideline ... #Management #Geriatrics ... #PPI #ProtonPumpInhibitors ... #Deprescribing
NOAC / DOAC Pharmacology and Prescribing Cheat Sheet
Novel (or Direct) Oral Anti-Coagulants
 • Rivaroxaban
 • Apixaban
NOAC / DOAC Pharmacology ... and Prescribing ... #NOAC #DOAC #Pharmacology ... #Prescribing #hematology ... #management #Direct
Eosinophilic Granulomatosis with Polyangiitis (EGPA) - ANCA Vasculitis Management Algorithm - ACR/VF 2021 Guidelines
 • Active
Granulomatosis with Polyangiitis ... ANCA Vasculitis Management ... - ACR/VF 2021 Guidelines ... Granulomatosis #Polyangiitis ... #algorithm #rheumatology
Guidelines for Perioperative Management of Antirheumatic Medication in Patients with Rheumatic Diseases Undergoing Elective Total Hip
Guidelines for Perioperative ... Management of Antirheumatic ... MithuRheum #rheumatology ... #management #autoimmune ... #pharmacology #